Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 5Gastrointestinal 2Tumor-Agnostic 1Dermatologic 1

Conditions

Skin Neoplasms 1Rosacea 1Psoriasis 1Melanoma 1Dermatitis, Atopic 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 195aldesleukin 148Interleukin-2 110fludarabine phosphate 107trametinib 85Temozolomide 83fludarabine 81Dacarbazine 81dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Magnetic Resonance Spectroscopy 50Specimen Handling 49Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Aminolevulinic Acid 49binimetinib 48Carboplatin 48Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Eating × Dermatologic × Clear all
NCT03253666 2020-07-15

Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)

Harvard School of Public Health (HSPH)

Completed
173,229 enrolled
Dermatologic

Dermatitis, Atopic, Melanoma, Psoriasis, Rosacea, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡